Silence Therapeutics (SLN) Return on Capital Employed [ROCE] (2022 - 2026)
Silence Therapeutics (SLN) reported Return on Capital Employed [ROCE] of -69.66% for the quarter ended Jun 30, 2026, down 15.63 percentage points from -54.03% a year earlier and down 0.17 percentage points from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics posted Return on Capital Employed [ROCE] of -59.36%, down 15.46 percentage points from the prior year.
- By year, Return on Capital Employed [ROCE] came in at -43.90% in the year ended Dec 31, 2024.
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -72.57% in the quarter ended Dec 31, 2025 and a high of -49.31% in the quarter ended Mar 31, 2025.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -69.49% (quarter ended Mar 31, 2026), -72.57% (quarter ended Dec 31, 2025) and -59.85% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Silence Therapeutics | 935.01 Mn | 862.91 Mn | - | -69.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.66% |
| Mar 31, 2026 | -69.49% |
| Dec 31, 2025 | -72.57% |
| Sep 30, 2025 | -59.85% |
| Jun 30, 2025 | -54.03% |
| Mar 31, 2025 | -49.31% |
| Dec 31, 2024 | -12.67% |
| Sep 30, 2024 | -9.46% |
| Jun 30, 2024 | -8.88% |
| Mar 31, 2024 | -13.53% |
| Dec 31, 2023 | -21.31% |
| Sep 30, 2023 | -11.07% |
| Jun 30, 2023 | -10.84% |
| Mar 31, 2023 | -11.52% |
| Dec 31, 2022 | -24.70% |
| Sep 30, 2022 | -137.96% |
API Access
Silence Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();